新型冠状病毒肺炎疫情下死亡病例报告分析的现状、思考与建议

医生在日常临床工作中,死亡病例讨论是必不可少的工作内容之一,而在突发公共卫生事件中,对死亡病例的报告与分析则有更深远的意义。新型冠状病毒肺炎疫情为我国带来巨大损失,医疗系统承受巨大压力,而战胜疫情的有利武器便是医疗数据及相关科学研究,死亡病例的系统分析与高效利用是关键一步。该文基于疫情下死亡病例报告记录不完善、人文视角与患者报告缺乏等现状,针对各部门机构面临巨大的数据管理压力,相关制度有待完善,规范化报告和临床科研一体化工作尚不成熟等问题提出方法学思考与建议:①建立国家医药健康数据中心,完善相关法律法规;②加大医药数据管理投入,疫情期间尽早开始数据收集与分析;③完善死亡病例报告相关内容,促进规范化报告形成;④重视死亡病例报告,回顾总结分析,强调疫情过后继续建立并完善相关平台与方案,开展相关科学研究,提升健康卫生数据管理效率,提高医疗系统抗风险能力,促进健康中国战略稳步前进。

Thoughts and suggestions on analysis of death cases report during COVID-19 epidemic

It is an essential task to discuss the death cases for clinicians. During the emergent public events, the report and analysis of death cases is of far-reaching significance. The epidemic of coronavirus disease 2019(COVID-19) has brought huge losses to China, and the medical system has been sustaining tremendous pressure. The best weapon to defeat the epidemic is medical data and related scientific research, of which the systematic analysis and efficient use of death cases is a key step. Based on the incomplete record of death case report, the lack of humanistic perspective and patient report, every department and institution is facing great challenge in terms of data management. Given that the relevant systems need to be improved, and that the integration of standardized reports and clinical research is not mature,as well as other problems, we put forward several methodological suggestions: ① Establish national medical and health data center and improve relevant laws and regulations. ② Increase investment in medical data management and start data collection and analysis as early as possible during the epidemic. ③ Refine the content of death case report and promote the standardization of report. ④ Pay close attention to the report of death cases, review, summary and analysis. More importantly, we should continue to build and improve platforms and programs related to disease control, carry out epidemic-associated scientific research, enhance the managing efficiency of public health data, elevate the anti-risk capability of our medical system, and promote the steady progress of the health China strategy.